Patients with recurrence (33/64) had higher expression of CXCL1 than those without recurrence (31/64) in both HCC tissues (P = 0.023) and serum (P = 0.011) (Figure 1F, 1G, 1H). This evidence concerns the gene CXCL1 and hepatocellular carcinoma.